Royalty Pharma Increases Bid for Elan
Royalty says it will pay $12.50 in cash for each share of Elan.
-
Business
Featured Story
-
Marketing & Advertising
Featured Story
IFPMA Launches 'Do You Mind?' Campaign
Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders GENEVA , May 21, 2013 /PRNewswire...
-
R&D
Featured Story
FDA, Peregrine Agree on Phase III Bavituximab Study
Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...
-
Therapeutics
Featured Story
Pfizer Halts Study of Non-Hodgkin's Lymphoma Drug
An interim analysis showed the drug wasn't helping patients live longer
-
Pharmalot
Featured Story
Pharmalot... Pharmalittle... Good Morning
Rise and shine, everyone. Another busy day is on the way, and we are no exception. We have an interesting meeting planned and, of course, various...
- Resources
- Directories
- Manny Awards
- Events
- Jobs